Journal of Applied Physiology Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 59: 360-364, 1985;
8750-7587/85 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milledge, J. S.
Right arrow Articles by Cotes, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milledge, J. S.
Right arrow Articles by Cotes, P. M.

Journal of Applied Physiology, Vol 59, Issue 2 360-364, Copyright © 1985 by American Physiological Society

ARTICLES

Serum erythropoietin in humans at high altitude and its relation to plasma renin

J. S. Milledge and P. M. Cotes

Serum immunoreactive erythropoietin (siEp) was estimated in samples collected from members of two scientific and mountaineering expeditions, to Mount Kongur in Western China and to Mount Everest in Nepal. SiEp was increased above sea-level control values 1 and 2 days after arrival at 3,500 m and remained high on ascent to 4,500 m. Thereafter, while subjects remained at or above 4,500 m, siEp declined, and by 22 days after the ascent to 4,500 m was at control values but increased on ascent to higher altitude. Thus siEp was at a normal level during the maintenance of secondary polycythemia from high-altitude exposure. On descent, with removal of altitude hypoxia, siEp decreased, but despite secondary polycythemia levels remained measurable and in the range found in subjects normally resident at sea level. On Mount Everest, siEp was significantly (P less than 0.01) elevated above preexpedition sea-level controls after 2-4 wk at or above 6,300 m. There was no correlation between estimates of siEp and plasma renin activity in samples collected before and during both expeditions.


This article has been cited by other articles:


Home page
 BloodHome page
J. L. Spivak and R. T. Silver
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
Blood, July 15, 2008; 112(2): 231 - 239.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. J. Gore, F. A. Rodriguez, M. J. Truijens, N. E. Townsend, J. Stray-Gundersen, and B. D. Levine
Increased serum erythropoietin but not red cell production after 4 wk of intermittent hypobaric hypoxia (4,000-5,500 m)
J Appl Physiol, November 1, 2006; 101(5): 1386 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G Mustacchi, R Ceccherini, C Dellach, S Foladore, S Milani, M Leita, and M Sisto
An induction dose of epoetin {alpha} of 40 000 IU daily for three consecutive days increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy
Ann. Onc., November 1, 2006; 17(11): 1705 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Asia Pac J Public HealthHome page
Y. Ohno, K. Hirai, S. Sakata, S. Shimizu, Y. Akai, K. Ogoshi, S. Sherchand, R. Gurung, J.B. Sherchand, and M.P. Shrestha
Nutritional Status of People Living in Dzong Village, in the Northern Mountainous Area of Nepal
Asia Pac J Public Health, September 1, 2006; 18(3): 20 - 29.
[PDF]

Home page
 Mayo Clin Proc.Home page
A. Tefferi and T. Barbui
bcr/abl-Negative, Classic Myeloproliferative Disorders: Diagnosis and Treatment
Mayo Clin. Proc., September 1, 2005; 80(9): 1220 - 1232.
[Abstract] [PDF]

Home page
 The OncologistHome page
E. Cortesi, A. Mancuso, A. De Pasquale Ceratti, N. Pizzardi, G. D'Auria, C. Accettura, P. Beccaglia, D. Bertelletti, and F. De Marinis
Effectiveness and Safety of an Induction Therapy with Epoetin Alfa in Anemic Cancer Patients Receiving Concomitant Chemotherapy
Oncologist, July 1, 2004; 9(4): 459 - 468.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
A. Tefferi
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
Mayo Clin. Proc., February 1, 2003; 78(2): 174 - 194.
[Abstract] [PDF]

Home page
 J. Appl. Physiol.Home page
R.-L. Ge, S. Witkowski, Y. Zhang, C. Alfrey, M. Sivieri, T. Karlsen, G. K. Resaland, M. Harber, J. Stray-Gundersen, and B. D. Levine
Determinants of erythropoietin release in response to short-term hypobaric hypoxia
J Appl Physiol, June 1, 2002; 92(6): 2361 - 2367.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
R. E. Paul, T. N. Coulson, A. Raibaud, and P. T. Brey
Sex Determination in Malaria Parasites
Science, January 7, 2000; 287(5450): 128 - 131.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
R. F. Chapman, J. Stray-Gundersen, and B. D. Levine
Individual variation in response to altitude training
J Appl Physiol, October 1, 1998; 85(4): 1448 - 1456.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
R. W. Kurz, F. Stockenhuber, C. Jahn, C. Wurnig, and P. Balcke
Serum-Erythropoietin Concentration During Acute Cardiogenic Pulmonary Edema
Angiology, April 1, 1991; 42(4): 281 - 288.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
A. R. Nissenson, S. D. Nimer, and D. L. Wolcott
Recombinant Human Erythropoietin and Renal Anemia: Molecular Biology, Clinical Efficacy, and Nervous System Effects
Ann Intern Med, March 1, 1991; 114(5): 402 - 416.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online